Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy

被引:0
|
作者
Li Zhuo
Nianrong Zhang
Guming Zou
Dapeng Chen
Wenge Li
机构
[1] China–Japan Friendship Hospital,Department of Nephrology
来源
Frontiers of Medicine | 2017年 / 11卷
关键词
diabetic nephropathy; clinical characteristics; renal biopsy; outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
Kidney damage is common in patients with diabetes mellitus (DM). However, whether the type of kidney damage can be reliably diagnosed using clinical data alone remains unclear. Predictive factors for diabetic nephropathy (DN) outcomes are also poorly understood. In this study, the clinical manifestations of 111 cases of biopsy-proven DN were described, and the clinical and pathological parameters of patients with different DN outcomes were compared. Results showed that long DM duration ( > 10 years in 32.4% of patients), severe proteinuria (62.2%), and renal dysfunction (estimated glomerular filtration rate [eGFR] < 60 mL/(min$1.73 m2)) (52.3%) did not accurately indicate whether the condition of these patients progressed to DN. Hematuria (48.6%) failed to specify either DN or nondiabetic renal disease. Diabetic retinopathy (78.4%) was a crucial complication in patients with DN. Kaplan–Meier analysis revealed that the renal survival of 53 patients who were diagnosed with DN and were followed up was not significantly associated with glomerular classification (P > 0.05). Cox’s regression analysis demonstrated that renal survival time was significantly influenced by sex (β = 1.394, P = 0.038), hematuria (β = 0.036, P = 0.029), and eGFR (β =–0.039, P = 0.002) but was not significantly affected by age, 24 h urinary protein excretion, or glomerular classification (P > 0.05). In conclusion, the clinical characteristics of DN vary, and renal biopsy is necessary to determine renal damage patterns. Sex, hematuria, and the eGFR may affect DN outcomes, whereas the glomerular classification may not.
引用
收藏
页码:386 / 392
页数:6
相关论文
共 50 条
  • [41] Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis
    Alice Corthier
    Marie Jachiet
    Daniel Bertin
    Aude Servais
    Christelle Barbet
    Adrien Bigot
    Marie-Sylvie Doutre
    Didier Bessis
    Ancuta Bouffandeau
    Olivier Moranne
    Pierre-André Jarrot
    Nathalie Bardin
    Benjamin Terrier
    Stephane Burtey
    Xavier Puéchal
    Laurent Daniel
    Noémie Jourde-Chiche
    BMC Nephrology, 23
  • [42] Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
    L. Zhao
    Y. Zhang
    F. Liu
    H. Yang
    Y. Zhong
    Y. Wang
    S. Li
    Q. Su
    L. Tang
    L. Bai
    H. Ren
    Y. Zou
    S. Wang
    S. Zheng
    H. Xu
    L. Li
    J. Zhang
    Z. Chai
    M. E. Cooper
    N. Tong
    Journal of Endocrinological Investigation, 2021, 44 : 2709 - 2723
  • [43] Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
    Zhao, L.
    Zhang, Y.
    Liu, F.
    Yang, H.
    Zhong, Y.
    Wang, Y.
    Li, S.
    Su, Q.
    Tang, L.
    Bai, L.
    Ren, H.
    Zou, Y.
    Wang, S.
    Zheng, S.
    Xu, H.
    Li, L.
    Zhang, J.
    Chai, Z.
    Cooper, M. E.
    Tong, N.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (12) : 2709 - 2723
  • [44] Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
    Tao, Sibei
    Li, Lingzhi
    Li, Ling
    Liu, Yuan
    Ren, Qian
    Shi, Min
    Liu, Jing
    Jiang, Jing
    Ma, Huichao
    Huang, Zhuo
    Xia, Zijing
    Pan, Jing
    Wei, Tiantian
    Wang, Yan
    Li, Peiyun
    Lan, Tian
    Tang, Xi
    Zeng, Xiaoxi
    Lei, Song
    Tang, Huairong
    Ma, Liang
    Fu, Ping
    ACTA DIABETOLOGICA, 2019, 56 (05) : 581 - 592
  • [45] Biopsy-proven Streptococcus suis-associated Infectious Glomerulonephritis
    Kajitani, Hideto
    Nishiwaki, Hiroki
    Ueno, Toshiharu
    Koiwa, Fumihiko
    Iwasaki, Shigeki
    Hirade, Satoshi
    INTERNAL MEDICINE, 2022, 61 (08) : 1201 - 1204
  • [46] Predicting biopsy-proven prostate cancer recurrence following cryosurgery
    Caso, Jorge R.
    Tsivian, Matvey
    Mouraviev, Vladimir
    Polascik, Thomas J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 391 - 395
  • [47] Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
    Golbin, Leonard
    Vigneau, Cecile
    Touchard, Guy
    Thervet, Eric
    Halimi, Jean-michel
    Sawadogo, Theophile
    Lagoutte, Nathan
    Siohan, Pascale
    Zagdoun, Elie
    Hertig, Alexandre
    Rioux-Leclercq, Nathalie
    Frouget, Thierry
    CLINICAL KIDNEY JOURNAL, 2017, 10 (03) : 381 - 388
  • [48] The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review
    Yang, Yue
    Zhang, Zheng
    Zhuo, Li
    Chen, Da-Peng
    Li, Wen-Ge
    CHINESE MEDICAL JOURNAL, 2018, 131 (06) : 731 - +
  • [49] Detrimental impact of early biopsy-proven rejection in liver transplantation
    Aufhauser Jr, David D.
    Stalter, Lily
    Marka, Nicholas
    Leverson, Glen
    Al-Adra, David P.
    Foley, David P.
    CLINICAL TRANSPLANTATION, 2024, 38 (01)
  • [50] The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review
    Yang Yue
    Zhang Zheng
    Zhuo Li
    Chen Da-Peng
    Li Wen-Ge
    中华医学杂志英文版, 2018, 131 (06) : 731 - 735